Every trade has a personality. Every trade represents an

New Post Public Reply Private Reply Replies (1) Message Board
Stock Buff MaxShockeR #109

Every trade has a personality. Every trade represents an opportunity for success and an opportunity for failure. The choices you make about what, when, and how much define your success. You make those choices based on the personality of the particular trade. Options are perhaps the most personality driven of all trading instruments.

Understanding the different strategies available for use in options trading is like a golfer understanding the different clubs in his/her bag. A driver in a very useful club, but should not be used in every situation on the golf course. It is awfully hard to putt with your driver. It is equally as hard to chip out of the sand with a putter. Let us look at a pretty common personality for options—a bullish credit spread—and how that personality should be played in the market: just like the right club should be played on the golf course.

A bullish credit spread should not be used in every scenario in the market. It is important for you, as a trader, to know the different trading tools available for any market scenario. Meet a bullish credit spread here, and understand its personality.

                                         Profit/Loss Diagram of Bull Put Spread

 

One of the key trading tools I employ regularly is the bullish put vertical, or Bull Put. This trade is applied in a stagnant or stagnant-to-bullish trend. The bullish trend can be slight, moderate, or accelerated. You will be selling a Put and buying a Put simultaneously. The Put that you short (sell) will be at a higher strike price than the Put that you long (buy), and therefore you will generate a credit to your account. This credit is your maximum profit. The strategy with this trade is to capture the effects of time decay on the option sold, as well as take advantage of a bullish move in the stock. The put option that you long (buy) is your hedge, in case the stock moves quickly in the other direction.

Primary and Secondary Exit Strategies

As with all trades it is important to have both a primaryandsecondaryexitstrategy . If you miss the green on the golf course, what will you do to save par? The primary exit strategy for the Bull Put trade is to let both the long put and the short put options that you hold expire worthless. The added benefit to this exit strategy is that you will eliminate the commissions on the back end of the trade by simply allowing the options to expire worthless. The secondary exit strategy can involve either closing out the position for a small pre-determined loss or convert the trade into a collar trade. Let’s take a look at an example.

Example:

1. You “sell to open” a July 50 Put for XYZ Corp. @ $1.50 per share;

2. You “buy to open” a July 45 Put for XYZ Corp. @ $0.50 per share;

3. Your net credit for the trade: ($1.50 - $0.50) = $1.00;

4. With one contract per leg (a total of 2) you would generate a profit (credit) of $100.

Rules of the Game: Basic Rules to Follow When Applying Credit Spread Trades

1.  Use Out of the Money (OTM) options. Credit spreads can be written At The Money, but have a higher risk of assignment. By structuring this trade in a way where you are writing an option far from the current stock price, it increases your probability of success with the trade.

2.   Look for options high in implied volatility . Overpriced options are generally a good thing to sell. Oftentimes there is a reason why implied volatility is high, so make sure there is not significant fundamental risk in the stock before placing.

3.  Use strike prices that are side by side. Try to stay to 5-point spreads when using short-term credit spread trades. You can go smaller if they are available. The closer together your spread, the lower your risk.

4.  Trade with the market trend. Do your due diligence. This is a trade that truly does follow the old saying, “The trend is your friend”.

5.  Where is the risk in this trade?

a. We have an OBLIGATION to buy the equity at the strike price of the short put;

b. We have the RIGHT to sell the same equity at the strike price of the long put;

c. Our risk is the difference between those two actions;

d. (However, we do get to keep the net credit.)

6.  Short Put is best placed at or below support.

7.  Do not place this trade during an option series where a scheduled news event (like earnings) could cause the equity to change its direction rapidly.

8.  Set a minimum and a maximum credit needed based on the time until expiration and your tolerance for risk.

9.  Time decay is an ally (this is a credit trade).

10. Long Put is used to minimize and control risk.

     a. You can use spreads as small as $1.00, when available, if you wish.

There is an old saying, “You’ll never go broke taking a profit.” This is the strategy behind credit spread trades . Put money in your pocket . It may not be a significant amount of money but, when structured correctly, these trades have a very high ratio of success. Winning more consistently is the single most important thing a trader can do. Understanding the personality of the trade will allow you to make the right decisions on how to play it, and increase your profitability. Trading, like golf, is a game of practice, discipline, and skill.

For more information on how to structure other trades like the Bull Put and how to adjust losing trades into winning trades, visit www . optionsanimal . com .

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Arclin's Bold Bet: Expanding Nomex Capacity in Spain

Updated Category News Views 5

Arclin's Strategic Move for Nomex® Expansion Looks like Arclin’s not messing around. They're throwing some serious cash down in Asturias, Spain, to ramp up production of Nomex®—a material hotter than a blacktop in July with demand surging across aerospace, electric vehicles, and defense sectors. "When we bought the Nomex® business, we committed to investing in its...

Continue Reading
Unicycive Faces Stock Plunge and Legal Woes After FDA Setback

Updated Category News Views 5

Unicycive's Rough Ride: Not Just a Bump Picture this: Your stock takes a nosedive over 39% in a day, just after a critical drug application gets slammed by the FDA—for the second time. That’s the story with Unicycive Therapeutics, Inc., ticker NASDAQ: UNC, a company that's been handing out one nail-biting moment after another to its investors. It's not just a minor...

Continue Reading
ELEGOO's M1 Ultra: Bridging Gap in 3D Scanning Tech

Updated Category News Views 0

A Leap in 3D Scanning: Say Hello to M1 Ultra ELEGOO isn't just fiddling with a toy here—this Shenzhen-based juggernaut is rolling out the M1 Ultra on October 29, 2026, and it's causing quite a stir. While the stock market doesn't see immediate tremors from every shiny new gadget, there’s something to say when a company that pulled over $300 million in sales last year...

Continue Reading
Side Bolsters Art Division with Roboto Acquisition

Updated Category News Views 7

Breaking Into China's Game Art Market The gaming industry's latest buzz centers around Side's acquisition of Roboto Entertainment, a boutique art studio known for crafting immersive game environments. This isn't just another headline grab—this move puts Side smack dab in the heart of China's burgeoning game market with a fresh Chengdu base. Expansion With Strategic...

Continue Reading
S&T Bancorp Hits Record Highs in Q3 2026

Updated Category News Views 3

Surpassing Expectations with Record Metrics Well, if it isn’t another stellar quarter for S&T Bancorp (NASDAQ:STBA). The folks over in Indiana, PA, just threw down some serious numbers. The third quarter of 2026 saw net income climbing to $38.6 million, up from $36.6 million last quarter. That's a decent hike if you ask me. But what really stole the spotlight here was...

Continue Reading
Savarese Joins RID to Drive Diagnostic Innovation

Updated Category News Views 5

A Seasoned Leader Bolsters RID's Ambitions Mario Savarese has joined Rapid Infection Diagnostics Inc.'s Strategic Advisory Board, and let me tell ya, this move's got potential. Appointing a heavyweight like Savarese as an advisor isn’t just a nod to his hefty resume. It’s about vaulting a burgeoning company into the big leagues. He's got over 20 years steering a ship...

Continue Reading
Tairex's AI System Targets Global Healthcare Gaps

Updated Category News Views 6

AI Meets Human Expertise in Clinical Decision-Making Look, in the labyrinth of healthcare, we’re seeing a revolution with AI stepping in—not to replace the doctor, but to stand alongside them like a trusty assistant. Tairex, from the halls of Tsinghua University's Institute for AI Industry Research (AIR), has thrown its hat into this ring by unveiling their...

Continue Reading
Montega Kicks Off Agilyx Sponsored Equity Research

Updated Category News Views 1

A Fresh Take on Agilyx's Market Standing Alright, folks. Agilyx ASA just got a new ticket for the analytical rodeo as Montega AG dives into sponsored equity research on the company. For those who aren't fluent in the arcane dialect of stock enthusiasts like yours truly, this means Agilyx now has another sharp set of eyes evaluating their every move, and let me tell you,...

Continue Reading
Nel ASA Welcomes Morten Holum as New CEO by 2027

Updated Category News Views 7

Nel ASA's New Leader Announced In the latest shake-up at Nel ASA (OSE: NEL), Morten Holum is getting ready to take the reins as CEO. By May 1, 2027, Holum will step into the shoes left by Håkon Volldal. And folks, this isn't your average leadership swap. Holum brings a hefty toolkit to this hydrogen powerhouse, having been part of the action across the hydrogen value...

Continue Reading
Amcor's Q3 2026 Results Loom: What's at Stake?

Updated Category News Views 3

Anticipation Builds for Amcor's Q3 2026 Financials Well, here we are again, staring down the barrel of another quarterly earnings report from Amcor plc (NYSE: AMCR). They've circled November 4th, 2026, in red on their calendars to dish out the numbers after the U.S. market's last bell rings. Investors, analysts, and the peanut gallery will be tuning in, and why not? At a...

Continue Reading

Top 5 Most Recently Viewed Articles

Ontex Group to Announce Shareholding Details Soon

Updated Category News Views 51

Significant Shareholding Notification by Ontex Group NV Ontex Group NV is committed to transparency and compliance with regulatory requirements. Recently, the company disclosed a significant shareholding notification that it received regarding Black Creek Investment Management Inc. This notification aligns with the Belgian Law concerning significant shareholdings in...

Continue Reading
TriNet Set to Announce First Quarter Results Soon

Updated Category News Views 154

TriNet's Upcoming Financial Report Announcement TriNet (NYSE: TNET), a prominent provider of human resources solutions tailored for small and medium-sized businesses (SMBs), is gearing up to reveal its financial results for the first quarter previously ended on March 31. The announcement is set to take place before the U.S. market opens on April 25. Details of the...

Continue Reading
PTC Therapeutics: Upcoming Q3 2025 Financial Results Call

Updated Category News Views 166

PTC Therapeutics Plans Third Quarter 2025 Financial Call PTC Therapeutics, Inc. (NASDAQ: PTCT) has announced that it will host a conference call to discuss its financial results for the third quarter of 2025. This upcoming event is set to take place on November 4 at 4:30 p.m. ET. It promises to provide valuable insights into the company's performance and strategic...

Continue Reading
Enhancing Maritime Safety with PntGuard™ Against Spoofing Threats

Updated Category News Views 201

Introducing PntGuard™ for Enhanced Maritime Security PntGuard™ is a revolutionary maritime-security solution designed to protect vessels from the dangers of GNSS spoofing and jamming. As the maritime sector faces growing threats from malicious disruptions of GNSS signals, PntGuard™ stands as a beacon of reliability, ensuring crews can navigate with confidence. This...

Continue Reading
Scienture Holdings Expands Market Reach with Arbli™ Agreements

Updated Category News Views 162

Scienture Holdings Enhances Healthcare Access with New Agreements Signifying a potential reach into about 20% of the U.S. institutional market, Scienture Holdings, Inc. (NASDAQ: SCNX) is paving the way for Arbli™ (losartan potassium) across a range of healthcare facilities. The U.S. losartan market, valued at $256 million annually, witnesses around 71 million...

Continue Reading